In patients with CKD, coronary artery calcification predicted the risk of CVD events, especially in those with no history of it.…
Read More »Intensive Type 1 Diabetes Therapy Lowers Kidney Failure Risk by 50 Percent
Intensive therapy for type 1 diabetes mellitus lowers the long-term risk for impaired glomerular filtration rate (GFR).…
Read More »Poor Glucose Control Ups Mortality in Diabetes Patients on Dialysis
Poor glycemic control, whether too high or too low, is associated with decreased survival in diabetic patients on hemodialysis….
Read More »Metabolic Syndrome Linked to Kidney Disease
Metabolic syndrome (MetS) and its components are linked to the development of chronic kidney disease (CKD), according to the results of a systematic review and meta-analysis.…
Read More »Earlier Nephrology Interventions Don’t Result in Lower Mortality Rates
Patients approaching end-stage renal disease are increasingly receiving the nephrology consultation they need before initiating kidney dialysis; however, the trend has surprisingly not resulted in an improvement in mortality rates, according to a new study.…
Read More »Why the FDA Said No to First In Class Dapagliflozin
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 9 to 6 against recommending the approval of the first in class novel antidiabetic agent dapagliflozin, largely because of fears that the product may cause breast and bladder cancer.… The EMDAC panel was also concerned about a lack of pharmacokinetic …
Read More »HbA1C Test Poorly Predictive in Dialysis Patients
Conventional glucose control monitoring methods may not be as meaningful in diabetes patients with end-stage renal disease, researchers found. Patients on dialysis will normally show a lower A1c than they actually have, giving patients and physicians a false sense of security.… The Gold standard long-term glucose monitoring test for patients …
Read More »Kidney Risk Determined Early in Life
Lifestyle decisions made before age 30 appear to determine a person’s risk of developing chronic kidney disease many years down the road….
Read More »Antifibrotic May Slow Diabetic Nephropathy
Diabetic nephropathy may not just slow but may actually improve with the novel antifibrotic agent pirfenidone (Esbriet).…
Read More »New Targets in Preventing End-Stage Renal Disease and Death of Diabetes Patients
Patients with both Type 1 diabetes and CKD have an increased risk of adverse outcomes….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.